182 related articles for article (PubMed ID: 31828152)
1. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
Xu L; Shen J; Jia J; Jia R
Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
[TBL] [Abstract][Full Text] [Related]
2. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
[TBL] [Abstract][Full Text] [Related]
3. SRSF3-Mediated Ki67 Exon 7-Inclusion Promotes Head and Neck Squamous Cell Carcinoma Progression via Repressing AKR1C2.
Liu M; Lin C; Huang Q; Jia J; Guo J; Jia R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835286
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract][Full Text] [Related]
5. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
Guo J; Jia J; Jia R
Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
[TBL] [Abstract][Full Text] [Related]
6. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
[TBL] [Abstract][Full Text] [Related]
8. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
[TBL] [Abstract][Full Text] [Related]
9. Expression of SRSF3 is Correlated with Carcinogenesis and Progression of Oral Squamous Cell Carcinoma.
Peiqi L; Zhaozhong G; Yaotian Y; Jun J; Jihua G; Rong J
Int J Med Sci; 2016; 13(7):533-9. PubMed ID: 27429590
[TBL] [Abstract][Full Text] [Related]
10. FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.
Jia R; Che X; Jia J; Guo J
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759731
[TBL] [Abstract][Full Text] [Related]
11. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
12. Underexpression of SRSF3 and its target gene RBMX predicts good prognosis in patients with head and neck cancer.
Guo J; Wang X; Jia J; Jia R
J Oral Sci; 2020 Mar; 62(2):175-179. PubMed ID: 32132325
[TBL] [Abstract][Full Text] [Related]
13. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
Ajiro M; Tang S; Doorbar J; Zheng ZM
J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
[TBL] [Abstract][Full Text] [Related]
14. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
[TBL] [Abstract][Full Text] [Related]
15. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1.
Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL
Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679
[TBL] [Abstract][Full Text] [Related]
16. Auto- and cross-regulation of the hnRNP L proteins by alternative splicing.
Rossbach O; Hung LH; Schreiner S; Grishina I; Heiner M; Hui J; Bindereif A
Mol Cell Biol; 2009 Mar; 29(6):1442-51. PubMed ID: 19124611
[TBL] [Abstract][Full Text] [Related]
17. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic SRSF3 in health and diseases.
Jia R; Zheng ZM
Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
[TBL] [Abstract][Full Text] [Related]
19. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
Wang X; Yan L; Guo J; Jia R
Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]